Lyell Immunopharma, Inc. (LYEL)
NASDAQ: LYEL · Real-Time Price · USD
0.701
+0.041 (6.17%)
At close: Feb 21, 2025, 4:00 PM
0.704
+0.003 (0.40%)
After-hours: Feb 21, 2025, 6:48 PM EST
Lyell Immunopharma Employees
Lyell Immunopharma had 224 employees as of December 31, 2023. The number of employees decreased by 50 or -18.25% compared to the previous year.
Employees
224
Change (1Y)
-50
Growth (1Y)
-18.25%
Revenue / Employee
$281
Profits / Employee
-$910,665
Market Cap
204.72M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 224 | -50 | -18.25% |
Dec 31, 2022 | 274 | 55 | 25.11% |
Dec 31, 2021 | 219 | 29 | 15.26% |
Dec 31, 2020 | 190 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
LYEL News
- 3 days ago - Lyell Immunopharma Announces Participation in Upcoming Investor Conferences - GlobeNewsWire
- 6 weeks ago - Lyell to Highlight Vision for its Next-Generation CAR T-Cell Therapy Pipeline at 43rd Annual JP Morgan Healthcare Conference - GlobeNewsWire
- 2 months ago - Lyell Presents Positive Initial Clinical Data from the Phase 1-2 Clinical Trial of IMPT-314 for the Treatment of B-cell Lymphoma at the 2024 ASH Annual Meeting - GlobeNewsWire
- 3 months ago - Lyell Announces Presentation of Initial Clinical Data from the Phase 1-2 Clinical Trial of IMPT-314 for the treatment of B-cell Lymphoma at the 2024 American Society of Hematology (ASH) Annual Meeting - GlobeNewsWire
- 4 months ago - Lyell Immunopharma Completes Acquisition of ImmPACT Bio - GlobeNewsWire
- 4 months ago - Lyell Immunopharma: Oversold And Poised For A Turning Point To Growth - Seeking Alpha
- 4 months ago - Lyell Immunopharma to Acquire ImmPACT Bio and Prioritizes its Pipeline to Focus on Next-Generation CAR T-cell Therapies - GlobeNewsWire
- 5 months ago - Lyell Immunopharma Announces the Acceptance Abstracts for Presentation at 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting - GlobeNewsWire